Photo of Brian Higgins
D United States House · District 26 · New York

Rep. Brian Higgins

Compare
Total votes
1,682
all sessions
Attendance
99%
19 missed
Near the chamber average
With party
98%
of cast votes
Higher than 79% of chamber peers
Bipartisan score
1%
crosses aisle rarely
Lower than 94% of chamber peers
Sponsored
648
bills & resolutions
Lower than 86% of chamber peers
Committees
0
assignments
648 bills and resolutions

Sponsored bills

Total
648
Primary
28
Co-sponsor
620
This page
648
matching current filters
Co-sponsor HRES 915
In committee Feb 9, 2022 1 co-sponsor
Co-sponsor HR 6660
In committee · United States House · Co-sponsor
First Rhode Island Regiment Congressional Gold Medal Act

First Rhode Island Regiment Congressional Gold Medal Act This bill provides for the award of a single Congressional Gold Medal to the First Rhode Island Regiment, collectively, in recognition of their dedicated service during the Revolutionary War.

In committee Feb 9, 2022 1 co-sponsor
Co-sponsor HR 6583
In committee · United States House · Co-sponsor
Stop the Wait Act of 2022

Stop the Wait Act of 2022 This bill allows individuals with disabilities to begin receiving Social Security Disability Insurance (SSDI) benefits in the month they become eligible for the benefits. It also allows these individuals to immediately enroll in Medicare if they cannot afford minimum essential coverage. (Under current law, an individual must generally wait 5 months after the onset of disability to begin receiving SSDI benefits and an additional 24 months to become eligible for Medicare.)

In committee Feb 4, 2022 1 co-sponsor
Co-sponsor HR 6557
In committee · United States House · Co-sponsor
Striking Workers Healthcare Protection Act

Striking Workers Healthcare Protection Act This bill prohibits an employer from terminating or significantly altering the employer-provided health insurance coverage of an employee engaged in a lawful strike. An employer that violates this prohibition is subject to a maximum civil penalty of $50,000 for each violation.

In committee Feb 2, 2022 1 co-sponsor
Co-sponsor HRES 884
In committee · United States House · Co-sponsor
Recognizing January 2022 as "National Mentoring Month".

Maddy summaryThis resolution (HRES 884) symbolically recognizes January 2022 as "National Mentoring Month" to highlight the value of mentoring relationships for youth. It does not create new laws or provide funding, but instead acknowledges mentoring's role in supporting young people's education, career development, and well-being. The resolution encourages promoting mentoring programs across communities, schools, and workplaces to address the "mentoring gap" where one in three youth lacks a supportive adult outside their home. As a procedural resolution, it has no direct legal effect on individuals or programs.

In committee Jan 20, 2022 1 co-sponsor
Co-sponsor HR 6405
In committee · United States House · Co-sponsor
Marriage Equality for Disabled Adults Act

Marriage Equality for Disabled Adults Act This bill eliminates certain marriage-related criteria for Social Security Disability Insurance benefits for Disabled Adult Children (DAC). It also expands access to Supplemental Security Income and Medicaid for married DAC recipients.

In committee Jan 14, 2022 1 co-sponsor
Primary HR 6330
In committee · United States House · Lead sponsor
Nonmarket Economy Overcapacity Reform Act

Nonmarket Economy Overcapacity Reform Act This bill requires the U.S. International Trade Commission (USITC) to consider additional factors in determining whether an industry in the United States is threatened with material injury by reason of imports or sales for importation of subject merchandise. In particular, the USITC must consider the effects of excess production capacity of subject merchandise from nonmarket economy countries.

In committee Jan 14, 2022 0 co-sponsors
Co-sponsor HR 6117
In committee · United States House · Co-sponsor
PrEP Access and Coverage Act

PrEP Access and Coverage Act This bill requires private health insurance plans to cover prescription drugs that prevent HIV, including related screenings, diagnostic procedures, administrative fees, and clinical follow-ups, without any cost-sharing obligation for the plan holder. Further, insurance plans must not impose any preauthorization requirement for this coverage. These coverage requirements also apply to public health insurance programs, including Medicare, Medicaid, and the Children's Health Insurance Program. Additionally, the bill prohibits denying, limiting, or qualifying coverage or increasing premiums for disability insurance, long-term care insurance, or life insurance policies based on an individual taking medication for HIV prevention. The bill further requires the Department of Health and Human Services to award grants to states, or directly to eligible local organizations, to provide uninsured individuals and underinsured individuals access to prescription drugs and related services that prevent HIV. The Centers for Disease Control and Prevention also must develop a public awareness campaign that focuses efforts in communities with a high need for HIV prevention treatment.

In committee Jan 6, 2022 1 co-sponsor
Co-sponsor HR 3537
Signed into law · United States House · Co-sponsor
Accelerating Access to Critical Therapies for ALS Act

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities for scientific research utilizing data from expanded access to investigational ALS treatments for individuals who are not otherwise eligible for clinical trials.  The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other rare neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases. The Government Accountability Office must report to Congress about the grants provided under this bill, including an analysis of the impact of such grants on research and development of treatments for ALS.

Signed into law Dec 23, 2021 1 co-sponsor
Co-sponsor HCONRES 65
In committee · United States House · Co-sponsor
Expressing the sense of the Congress that tax-exempt fraternal benefit societies have historically provided and continue to provide critical benefits to the people and communities of the United States.

This concurrent resolution expresses the sense of Congress that tax-exempt fraternal benefit societies provide critical benefits to the people and communities of the United States and their work should continue to be promoted.

In committee Dec 16, 2021 1 co-sponsor
Showing 371 to 380 of 648 bills
Previous 1 … 37 38 39 … 65 Next